MP Biomedicals

Santa Ana, United States Founded: 1959 • Age: 67 yrs Acquired By Valiant
Reagents for diagnostics, chemical and life science research
Annual revenue $4.1M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About MP Biomedicals

MP Biomedicals is a company based in Santa Ana (United States) founded in 1959 by Milan Panic was acquired by Valiant in October 2015. MP Biomedicals has completed 1 acquisition, including Qbiogene.

  • Headquarter Santa Ana, United States
  • Founders Milan Panic
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Mp Biomedicals India Private Limited
  • Date of Incorporation 01 Apr, 2009
  • Jurisdiction Navi Mumbai, Maharashtra, India
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.11 M (USD)
    -47.84
    as on Mar 31, 2023
  • Net Profit
    -$160.33 K (USD)
    -117.79
    as on Mar 31, 2023
  • EBITDA
    -$637.94 K (USD)
    -142.9
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Valiant

    (Oct 20, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of MP Biomedicals

Premium access

Detailed funding history for MP Biomedicals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in MP Biomedicals

MP Biomedicals has secured backing from 1 investor. Prominent investors backing the company include Valiant CN.

All
Investor Description Founded Year Domain Location
Pharmaceutical intermediates and optical chemical products are manufactured.
Locked Locked Locked
Premium access

Investor details for MP Biomedicals

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MP Biomedicals

MP Biomedicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Qbiogene.

Investments
Premium access

Investment portfolio details for MP Biomedicals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Molecular biology products are supplied by Qbiogene.
Locked Locked 0 Locked
Premium access

Complete acquisition details for MP Biomedicals

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - MP Biomedicals

Premium access

Detailed financials for MP Biomedicals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mp Biomedicals Comparisons

MP Biomedicals Primary company
Description
Reagents for diagnostics, chemical and life science research
Location
Santa Ana, United States
Founded Year
1959
Annual Revenue
$4.11 M (USD)
Net Profit
-$160.33 K (USD)
EBITDA
-$637.94 K (USD)
Employees
Not available
Premium access

Peer comparison for MP Biomedicals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of MP Biomedicals

Premium access

Detailed competitors of MP Biomedicals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mp Biomedicals

Premium access

Complete news archive for MP Biomedicals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MP Biomedicals

MP Biomedicals was founded in 1959.

MP Biomedicals is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.

Kimberly Keniston is the current CEO of MP Biomedicals.

Annual revenue of MP Biomedicals is $4.11M as on Mar 31, 2023.

MP Biomedicals was established in 1959 in Santa Ana, United States, by Milan Panic, a Serbian businessman and former Prime Minister of Yugoslavia. Reagents for diagnostics, chemical analysis, and life science research are provided through a product line exceeding 55,000 items, including assays, chemicals, labware, and instruments. Operations are centered on supporting laboratory and research applications in the biotechnology sector.

MP Biomedicals has made 1 acquisition, including Qbiogene.

MP Biomedicals has 1 investor. Key investors include Valiant CN.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available